Generic anti-seizure drugs’ costs went down during the same time, study shows

But low profitability remains a barrier.

Few people with HDHPs proactively ask about or search for lower-cost care. This suggests opportunity for insurers, employers and health care providers to help.

Many adults haven’t talked to their doctors, pharmacists or nurses about drug interactions, a new national poll finds.

The firestorm of controversy surrounding the epinephrine auto-injector’s rising prices raises additional issues about the U.S. pharma market.